Novo Nordisk A/S (NVO)

62.33 +5.21 (+9.12%) USD  |  NYSE  |  Jan 16, 16:00
60.21 -2.12 (-3.40%) Pre-Market: 07:07
More

Novo Nordisk Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for NVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Ascendis Pharma A/S Upgrade
Evaxion AS Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Omeros Corp. --
Viking Therapeutics, Inc. --